These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28891335)

  • 61. DNA Nanotechnology for Precise Control over Drug Delivery and Gene Therapy.
    Angell C; Xie S; Zhang L; Chen Y
    Small; 2016 Mar; 12(9):1117-32. PubMed ID: 26725041
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Advances in Designer DNA Nanorobots Enabling Programmable Functions.
    Wang M; Li X; He F; Li J; Wang HH; Nie Z
    Chembiochem; 2022 Sep; 23(18):e202200119. PubMed ID: 35491242
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nanocarriers based novel and effective drug delivery system.
    Khizar S; Alrushaid N; Alam Khan F; Zine N; Jaffrezic-Renault N; Errachid A; Elaissari A
    Int J Pharm; 2023 Feb; 632():122570. PubMed ID: 36587775
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Single-Molecule Characterization of Drug Delivery Systems.
    Okay S
    Assay Drug Dev Technol; 2020 Jan; 18(1):56-63. PubMed ID: 31573322
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
    Grumezescu AM; Chifiriuc CM
    Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cellular processing and destinies of artificial DNA nanostructures.
    Lee DS; Qian H; Tay CY; Leong DT
    Chem Soc Rev; 2016 Aug; 45(15):4199-225. PubMed ID: 27119124
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA Nanostructures as Smart Drug-Delivery Vehicles and Molecular Devices.
    Linko V; Ora A; Kostiainen MA
    Trends Biotechnol; 2015 Oct; 33(10):586-594. PubMed ID: 26409777
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nanosponges - a completely new nano-horizon: pharmaceutical applications and recent advances.
    Ahmed RZ; Patil G; Zaheer Z
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1263-72. PubMed ID: 22681585
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
    Liu X; Wu L; Wang L; Jiang W
    Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Self-Assembled Multivalent Aptamer Drug Conjugates: Enhanced Targeting and Cytotoxicity for HER2-Positive Gastric Cancer.
    Ma W; Yang Y; Liu Z; Zhao R; Wan Q; Chen X; Tang B; Zhou Y; Lin Y
    ACS Appl Mater Interfaces; 2023 Sep; 15(37):43359-43373. PubMed ID: 37670592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Engineering nucleic acid structures for programmable molecular circuitry and intracellular biocomputation.
    Li J; Green AA; Yan H; Fan C
    Nat Chem; 2017 Nov; 9(11):1056-1067. PubMed ID: 29064489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lymphatic targeting for therapeutic application using nanoparticulate systems.
    Singh N; Handa M; Singh V; Kesharwani P; Shukla R
    J Drug Target; 2022 Dec; 30(10):1017-1033. PubMed ID: 35722764
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Daunorubicin-Loaded DNA Origami Nanostructures Circumvent Drug-Resistance Mechanisms in a Leukemia Model.
    Halley PD; Lucas CR; McWilliams EM; Webber MJ; Patton RA; Kural C; Lucas DM; Byrd JC; Castro CE
    Small; 2016 Jan; 12(3):308-20. PubMed ID: 26583570
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Application of DNA origami in nanobiomedicine].
    Wang J; Zhang P; Xia Q; Wei Y; Chen W; Wang J; Li P; Li B; Zhou X
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):960-964. PubMed ID: 34238752
    [TBL] [Abstract][Full Text] [Related]  

  • 76. DNA-Assisted Smart Nanocarriers: Progress, Challenges, and Opportunities.
    Kim T; Nam K; Kim YM; Yang K; Roh YH
    ACS Nano; 2021 Feb; 15(2):1942-1951. PubMed ID: 33492127
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro and in vivo behavior of DNA tetrahedrons as tumor-targeting nanocarriers for doxorubicin delivery.
    Kang JH; Kim KR; Lee H; Ahn DR; Ko YT
    Colloids Surf B Biointerfaces; 2017 Sep; 157():424-431. PubMed ID: 28645043
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.
    Chen C; Yang Z; Tang X
    Med Res Rev; 2018 May; 38(3):829-869. PubMed ID: 29315675
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Design and application of DNA nanostructures for organelle-targeted delivery of anticancer drugs.
    Sun S; Yang Y; Niu H; Luo M; Wu ZS
    Expert Opin Drug Deliv; 2022 Jun; 19(6):707-723. PubMed ID: 35618266
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Functionalized-DNA nanostructures as potential targeted drug delivery systems for cancer therapy.
    Kumar A; Ahmad A; Ansari MM; Gowd V; Rashid S; Chaudhary AA; Rudayni HA; Alsalamah SA; Khan R
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):54-68. PubMed ID: 36087856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.